Blood tests for prediction of deep endometriosis: A case-control study

Table 2 Hemostatic parameters and inflammation indices of participants with or without deep endometriosis

Variable	Controls (n = 95)	DE (n = 31)	P value
PT (s)	12.91 ± 0.61	13.11 ± 0.59	0.11
INR	1.01 (0.98-1.04)	1.05 (1.00-1.07)	0.03
APTT (s)	36.11 ± 3.16	36.84 ± 3.18	0.27
TT (s)	15.56 ± 0.61	15.29 ± 0.56	0.03
Fg (g/L)	2.83 (2.53-3.14)	3.09 (2.73-3.97)	0.01
PLT (109/L)	228.00 (185.00-258.00)	235.00 (212.00-262.00)	0.32
HB (g/L)	130.00 (124.00-136.00)	126.00 (115.00-130.00)	0.02
WN (109/L)	3.90 (3.00-4.80)	3.30 (2.80-4.10)	0.27
WL (109/L)	1.65 (1.30-2.00)	1.60 (1.30-1.80)	0.34
MPV (fL)	8.60 (7.90-9.70)	8.40 (7.80-8.90)	0.23
PCT (%)	0.19 (0.17-0.22)	0.20 (0.18-0.23)	0.21
NLR	2.16 (1.59-3.20)	2.31 (1.58-2.78)	0.86
PLR	130.00 (108.82-180.00)	154.71 (128.95-179.09)	0.08
CRP (mg/L)	12.91 ± 0.61	13.11 ± 0.59	0.01

Data are mean ± SD for normally distributed variables and medians (Q1-Q3) for abnormal variables without a normal distribution. APTT: Activated partial thromboplastin time; CRP: C-reactive protein Fg: Fibrinogen; HB: Hemoglobin; INR: International standardized ratio; MPV: Mean platelet volume; NLR: Neutrophil-to-lymphocyte ratio; PCT: Platelet distribution width; PLR: Platelet-to-lymphocyte ratio; PLT: Platelet count; PT: Prothrombin time; TT: Thrombin time; WL: Lymphocyte number; WN: Neutrophil number.